Investor Presentaiton

however, the pharma grew in 2022 by 12.1% and expected to grow by ~15-16% in 2023 with a declining rate for the retail contribution ... Market Growth Drivers ■Retail ■Non-Retail Pharma Market Growth (Billions) 13-22 CAGR 15% Market Composition - Excluding Tender ■Retail Wholesale Private Hos. 183 159 6% 10% 6% 11% 8% 8% 142 14% 16% Q 120 111 63 92 56 74 29 41 15% 61 12% J \\ 51 28 44 84% 82% 24 78% 39 75% 20 19 14 16 83 79 86 96 64 50 25 28 32 41 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 Market Volume Evolution 13-22 CAGR 3.3% -10% -1% (F) 2019 2020 2021 2022 01 3,490 3,504 3,743 3,718 2,891 3,035 3,172 3,186 2,670 2,849 Average Selling Price 13-22 CAGR 11.3% 26.0 28.6 31.7 2013 2014 2015 35% 14.5 15.3 16.5 19.3 2016 2017 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 ibnsinapharma 13.1% 70 83 03 Ageing & Growing Population Increase of Chronic Diseases Increase of Generic Uptake Price Adjusting Waves Higher Priced Drug Replacements New Products Introduction Pharma Market Current Challenges As a result of the rising inflation rate and given that the market is price regulated; all pharmaceutical sector players are pressured with higher cost and squeezed margins Increasing interest & exchange rates impacted the financing expenses leading to higher debt level across all the pharma chain The wholesale sector contribution is steadily increasing from the total market. This sector is cash-based with high cash discount compared to the retail sector 02 42.7 37.74 34.2 2018 2019 2020 2021 2022(F) 3

View entire presentation